These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8349785)
21. Effects of differently oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro. Dominaitiene R; Lindgren S; Janciauskiene S In Vitr Mol Toxicol; 2001; 14(2):83-97. PubMed ID: 11690562 [TBL] [Abstract][Full Text] [Related]
22. Involvement of intracellular iron in the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Kuzuya M; Naito M; Yamada K; Funaki C; Hayashi T; Asai K; Kuzuya F Biochem Int; 1990 Nov; 22(3):567-73. PubMed ID: 2076112 [TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431 [TBL] [Abstract][Full Text] [Related]
24. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Kamanna VS; Pai R; Roh DD; Kirschenbaum MA Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611 [TBL] [Abstract][Full Text] [Related]
25. Effects of dexamethasone on migration of human monocytes in response to oxidized beta-very low density lipoprotein. Yamada K; Naito M; Hayashi T; Asai K; Yoshimine N; Iguchi A Artery; 1993; 20(5):253-67. PubMed ID: 8141646 [TBL] [Abstract][Full Text] [Related]
26. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Quinn MT; Parthasarathy S; Fong LG; Steinberg D Proc Natl Acad Sci U S A; 1987 May; 84(9):2995-8. PubMed ID: 3472245 [TBL] [Abstract][Full Text] [Related]
27. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Ohgushi M; Kugiyama K; Fukunaga K; Murohara T; Sugiyama S; Miyamoto E; Yasue H Arterioscler Thromb; 1993 Oct; 13(10):1525-32. PubMed ID: 8399090 [TBL] [Abstract][Full Text] [Related]
28. [Effects of oxidized low density lipoprotein and very low density lipoprotein on the expression of MCP-1 by monocytes]. Wang G; Deng Z; Qu Z Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):220-3. PubMed ID: 9275656 [TBL] [Abstract][Full Text] [Related]
29. Oxidative and malondialdehyde modification of low-density lipoprotein: a comparative study of binding and degradation by macrophages and endothelial cells. Zhou M; Chen Y; Liu S; Ding Z; Pang Z; Wan J Br J Biomed Sci; 1998 Sep; 55(3):192-8. PubMed ID: 10367404 [TBL] [Abstract][Full Text] [Related]
30. Sex hormones affect the calcium signaling response of human arterial cells to LDL. Wells KE; Miguel R; Alexander JJ J Surg Res; 1996 Jun; 63(1):64-72. PubMed ID: 8661174 [TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Quinn MT; Parthasarathy S; Steinberg D Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2805-9. PubMed ID: 3357891 [TBL] [Abstract][Full Text] [Related]
32. Regulation of endothelial cell protein C activation by native and oxidized low density lipoprotein. Wilson BD; Pitas RE; Rodgers GM Semin Thromb Hemost; 1992 Jan; 18(1):11-7. PubMed ID: 1574712 [TBL] [Abstract][Full Text] [Related]
33. Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Mehta JL; Li DY Biochem Biophys Res Commun; 1998 Jul; 248(3):511-4. PubMed ID: 9703956 [TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Yokoyama M; Hirata K; Miyake R; Akita H; Ishikawa Y; Fukuzaki H Biochem Biophys Res Commun; 1990 Apr; 168(1):301-8. PubMed ID: 2328007 [TBL] [Abstract][Full Text] [Related]
36. Oxidation decreases low density lipoprotein association with the subendothelium extracellular matrix. Savion N; Zavaro O; Kotev-Emeth S Biochem Biophys Res Commun; 1998 Apr; 245(2):497-501. PubMed ID: 9571183 [TBL] [Abstract][Full Text] [Related]
37. The standardized Ginkgo biloba extract Egb-761 protects vascular endothelium exposed to oxidized low density lipoproteins. Pierre SV; Lesnik P; Moreau M; Bonello L; Droy-Lefaix MT; Sennoune S; Duran MJ; Pressley TA; Sampol J; Chapman J; Maixent JM Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54 Suppl():OL1032-42. PubMed ID: 18954552 [TBL] [Abstract][Full Text] [Related]
38. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. Murugesan G; Fox PL J Clin Invest; 1996 Jun; 97(12):2736-44. PubMed ID: 8675684 [TBL] [Abstract][Full Text] [Related]
39. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. Sevanian A; Hodis HN; Hwang J; McLeod LL; Peterson H J Lipid Res; 1995 Sep; 36(9):1971-86. PubMed ID: 8558085 [TBL] [Abstract][Full Text] [Related]
40. Troglitazone-binding to LDL and its glycated modifications: its role in cell-catalysed and Cu-mediated LDL-oxidation. Sobal G; Sinzinger H; Menzel EJ Life Sci; 2000 Jun; 67(6):695-707. PubMed ID: 12659175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]